Drugs / Zegerid
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | ZEGERID | — | 2004-06-15 | fda.gov ↗ |
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT01129778 | Nov 2009 → Jul 2010 | Barrett esophagus, gastroesophageal reflux disease | Stanford University | Terminated | No outcome recorded Stop: Business |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Zegerid | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01129778 ↗ |
| Modality | Other / unclassified | “Drug: Zegerid (proton pump inhibitor)” NCT01129778 ↗ |